Maccura Non Current Liabilities Total from 2010 to 2024
| 300463 Stock | 13.94 0.07 0.50% |
Non Current Liabilities Total | First Reported 2019-03-31 | Previous Quarter 329.5 M | Current Value 362.6 M | Quarterly Volatility 135.6 M |
Check Maccura Biotechnology financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Maccura Biotechnology's main balance sheet or income statement drivers, such as Interest Expense of 28.5 M, Selling General Administrative of 478.8 M or Total Revenue of 2.5 B, as well as many indicators such as . Maccura financial statements analysis is a perfect complement when working with Maccura Biotechnology Valuation or Volatility modules.
Maccura | Non Current Liabilities Total |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Maccura Stock
Maccura Biotechnology financial ratios help investors to determine whether Maccura Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Maccura with respect to the benefits of owning Maccura Biotechnology security.